Evercore ISI Group upgraded the previous rating for US Silica Holdings Inc (NYSE:SLCA) from In-Line to Outperform. In the first quarter, US Silica Holdings showed an EPS of $0.02, compared to $0.28 from the year-ago quarter. The current stock performance of US Silica Holdings shows a 52-week-high of $21.54 and a 52-week-low of $7.22. Moreover, at the end of the last trading period, the closing price was at $13.48.

CIBC upgraded the previous rating for Thomson Reuters Corp (NYSE:TRI) from Neutral to Outperformer. In the first quarter, Thomson Reuters showed an EPS of $0.66, compared to $0.58 from the year-ago quarter. The current stock performance of Thomson Reuters shows a 52-week-high of $123.60 and a 52-week-low of $91.55. Moreover, at the end of the last trading period, the closing price was at $96.32.

Piper Sandler upgraded the previous rating for B&G Foods Inc (NYSE:BGS) from Underweight to Neutral. In the first quarter, B&G Foods showed an EPS of $0.34, compared to $0.52 from the year-ago quarter. The current stock performance of B&G Foods shows a 52-week-high of $36.52 and a 52-week-low of $21.05. Moreover, at the end of the last trading period, the closing price was at $21.98.

For Coinbase Global Inc (NASDAQ:COIN), JP Morgan downgraded the previous rating of Overweight to Neutral. For the first quarter, Coinbase Global had an EPS of $1.98, compared to year-ago quarter EPS of $3.05. The current stock performance of Coinbase Global shows a 52-week-high of $368.90 and a 52-week-low of $40.83. Moreover, at the end of the last trading period, the closing price was at $52.01.

According to B. Riley Securities, the prior rating for New York Community Bancorp Inc (NYSE:NYCB) was changed from Buy to Neutral. For the first quarter, New York Community had an EPS of $0.32, compared to year-ago quarter EPS of $0.29. The stock has a 52-week-high of $14.33 and a 52-week-low of $8.73. At the end of the last trading period, New York Community closed at $9.04.

B. Riley Securities downgraded the previous rating for The Bank of Princeton (NASDAQ:BPRN) from Buy to Neutral. In the first quarter, Bank of Princeton showed an EPS of $0.91, compared to $0.70 from the year-ago quarter. The current stock performance of Bank of Princeton shows a 52-week-high of $32.05 and a 52-week-low of $27.65. Moreover, at the end of the last trading period, the closing price was at $28.22.

B of A Securities downgraded the previous rating for Best Buy Co Inc (NYSE:BBY) from Buy to Neutral. For the first quarter, Best Buy Co had an EPS of $1.57, compared to year-ago quarter EPS of $2.23. The current stock performance of Best Buy Co shows a 52-week-high of $141.97 and a 52-week-low of $68.62. Moreover, at the end of the last trading period, the closing price was at $69.45.

B of A Securities downgraded the previous rating for The Chemours Co (NYSE:CC) from Buy to Neutral. Chemours earned $1.46 in the first quarter, compared to $0.71 in the year-ago quarter. The current stock performance of Chemours shows a 52-week-high of $44.95 and a 52-week-low of $22.56. Moreover, at the end of the last trading period, the closing price was at $38.48.

B of A Securities downgraded the previous rating for Huntsman Corp (NYSE:HUN) from Buy to Underperform. Huntsman earned $1.19 in the first quarter, compared to $0.66 in the year-ago quarter. The current stock performance of Huntsman shows a 52-week-high of $41.65 and a 52-week-low of $24.09. Moreover, at the end of the last trading period, the closing price was at $31.13.

For Bridgewater Bancshares Inc (NASDAQ:BWB), B. Riley Securities downgraded the previous rating of Buy to Neutral. For the first quarter, Bridgewater Bancshares had an EPS of $0.39, compared to year-ago quarter EPS of $0.37. The stock has a 52-week-high of $20.05 and a 52-week-low of $14.97. At the end of the last trading period, Bridgewater Bancshares closed at $15.55.

B. Riley Securities downgraded the previous rating for Peoples Bancorp Inc (Marietta OH) (NASDAQ:PEBO) from Buy to Neutral. In the first quarter, Peoples Bancorp showed an EPS of $0.88, compared to $0.90 from the year-ago quarter. At the moment, the stock has a 52-week-high of $34.63 and a 52-week-low of $26.56. Peoples Bancorp closed at $26.97 at the end of the last trading period.

For AeroClean Technologies Inc (NASDAQ:AERC), Benchmark downgraded the previous rating of Buy to Hold. In the first quarter, AeroClean Technologies showed an EPS of $0.19, compared to $0.14 from the year-ago quarter. The stock has a 52-week-high of $117.35 and a 52-week-low of $1.76. At the end of the last trading period, AeroClean Technologies closed at $17.25.

Deutsche Bank downgraded the previous rating for Hewlett Packard Enterprise Co (NYSE:HPE) from Buy to Hold. For the second quarter, Hewlett Packard had an EPS of $0.44, compared to year-ago quarter EPS of $0.46. At the moment, the stock has a 52-week-high of $17.76 and a 52-week-low of $12.99. Hewlett Packard closed at $13.70 at the end of the last trading period.

According to B. Riley Securities, the prior rating for Legacy Housing Corp (NASDAQ:LEGH) was changed from Buy to Neutral. In the third quarter, Legacy Housing showed an EPS of $0.61, compared to $0.35 from the year-ago quarter. At the moment, the stock has a 52-week-high of $28.84 and a 52-week-low of $14.07. Legacy Housing closed at $14.59 at the end of the last trading period.

UBS initiated coverage on Royalty Pharma PLC (NASDAQ:RPRX) with a Buy rating. The price target for Royalty Pharma is set to $47.00. For the first quarter, Royalty Pharma had an EPS of $0.60, compared to year-ago quarter EPS of $0.67. At the moment, the stock has a 52-week-high of $46.53 and a 52-week-low of $34.86. Royalty Pharma closed at $38.46 at the end of the last trading period.

With a Neutral rating, UBS initiated coverage on Teva Pharmaceutical Industries Ltd (NYSE:TEVA). The price target seems to have been set at $10.00 for Teva Pharmaceutical Indus. Teva Pharmaceutical Indus earned $0.55 in the first quarter, compared to $0.63 in the year-ago quarter. The current stock performance of Teva Pharmaceutical Indus shows a 52-week-high of $11.45 and a 52-week-low of $7.23. Moreover, at the end of the last trading period, the closing price was at $7.89.

With a Market Outperform rating, CJS Securities initiated coverage on Kaman Corp (NYSE:KAMN). The price target seems to have been set at $45.00 for Kaman. For the first quarter, Kaman had an EPS of $0.15, compared to year-ago quarter EPS of $0.29. The current stock performance of Kaman shows a 52-week-high of $55.48 and a 52-week-low of $32.31. Moreover, at the end of the last trading period, the closing price was at $35.31.

B. Riley Securities initiated coverage on Lineage Cell Therapeutics Inc (AMEX:LCTX) with a Buy rating. The price target for Lineage Cell Therapeutics is set to $4.00. Lineage Cell Therapeutics earned $0.04 in the first quarter, compared to $0.01 in the year-ago quarter. At the moment, the stock has a 52-week-high of $3.00 and a 52-week-low of $1.10. Lineage Cell Therapeutics closed at $1.30 at the end of the last trading period.

With a Neutral rating, UBS initiated coverage on Coherus BioSciences Inc (NASDAQ:CHRS). The price target seems to have been set at $7.00 for Coherus BioSciences. For the first quarter, Coherus BioSciences had an EPS of $1.00, compared to year-ago quarter EPS of $0.01. The stock has a 52-week-high of $19.32 and a 52-week-low of $6.09. At the end of the last trading period, Coherus BioSciences closed at $6.19.

With a Buy rating, UBS initiated coverage on Intra-Cellular Therapies Inc (NASDAQ:ITCI). The price target seems to have been set at $75.00 for Intra-Cellular Therapies. Intra-Cellular Therapies earned $0.78 in the first quarter, compared to $0.65 in the year-ago quarter. At the moment, the stock has a 52-week-high of $66.00 and a 52-week-low of $28.40. Intra-Cellular Therapies closed at $53.07 at the end of the last trading period.

With a Buy rating, UBS initiated coverage on Jazz Pharmaceuticals PLC (NASDAQ:JAZZ). The price target seems to have been set at $194.00 for Jazz Pharmaceuticals. For the first quarter, Jazz Pharmaceuticals had an EPS of $3.73, compared to year-ago quarter EPS of $3.92. The stock has a 52-week-high of $189.00 and a 52-week-low of $117.64. At the end of the last trading period, Jazz Pharmaceuticals closed at $141.59.

UBS initiated coverage on Horizon Therapeutics PLC (NASDAQ:HZNP) with a Buy rating. The price target for Horizon Therapeutics is set to $139.00. Horizon Therapeutics earned $1.34 in the first quarter, compared to $0.03 in the year-ago quarter. The stock has a 52-week-high of $120.53 and a 52-week-low of $81.20. At the end of the last trading period, Horizon Therapeutics closed at $81.60.

Oppenheimer initiated coverage on Ashford Inc (AMEX:AINC) with an Outperform rating. The price target for Ashford is set to $28.00. In the first quarter, Ashford showed an EPS of $1.50, compared to $0.65 from the year-ago quarter. The current stock performance of Ashford shows a 52-week-high of $25.99 and a 52-week-low of $12.22. Moreover, at the end of the last trading period, the closing price was at $16.02.

With an Outperform rating, BMO Capital initiated coverage on Marathon Petroleum Corp (NYSE:MPC). The price target seems to have been set at $135.00 for Marathon Petroleum. Marathon Petroleum earned $1.49 in the first quarter, compared to $0.20 in the year-ago quarter. At the moment, the stock has a 52-week-high of $114.35 and a 52-week-low of $50.19. Marathon Petroleum closed at $102.17 at the end of the last trading period.

BMO Capital initiated coverage on Phillips 66 (NYSE:PSX) with an Outperform rating. The price target for Phillips 66 is set to $132.00. For the first quarter, Phillips 66 had an EPS of $1.32, compared to year-ago quarter EPS of $1.16. At the moment, the stock has a 52-week-high of $111.28 and a 52-week-low of $63.19. Phillips 66 closed at $101.44 at the end of the last trading period.

With a Market Perform rating, BMO Capital initiated coverage on Valero Energy Corp (NYSE:VLO). The price target seems to have been set at $155.00 for Valero Energy. In the first quarter, Valero Energy showed an EPS of $2.31, compared to $1.73 from the year-ago quarter. The stock has a 52-week-high of $146.81 and a 52-week-low of $58.85. At the end of the last trading period, Valero Energy closed at $131.61.

Credit Suisse initiated coverage on Chesapeake Energy Corp (NASDAQ:CHK) with an Outperform rating. The price target for Chesapeake Energy is set to $115.00. Chesapeake Energy earned $3.09 in the first quarter, compared to $1.48 in the year-ago quarter. The stock has a 52-week-high of $105.00 and a 52-week-low of $48.19. At the end of the last trading period, Chesapeake Energy closed at $93.37.